Relationship of glycemia control to lipid and blood pressure lowering and atherosclerosis: the SANDS experience
- PMID: 21775166
- PMCID: PMC3222781
- DOI: 10.1016/j.jdiacomp.2011.04.001
Relationship of glycemia control to lipid and blood pressure lowering and atherosclerosis: the SANDS experience
Abstract
Objectives: Cardiovascular disease prevention for patients with type 2 diabetes is accomplished through hypertension and dyslipidemia management. Although studies have established strategies for lowering low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP), none have examined whether glycemia influences ability to achieve lipid and BP targets. This post hoc analysis from the Stop Atherosclerosis in Native Diabetics Study examines the role of baseline glycemia in achieving standard and aggressive targets and outcomes after 36 months.
Methods: Diabetic individuals aged > 40 years with no cardiovascular events (n = 499) were randomized to aggressive versus standard targets for LDL-C, non-high-density lipoprotein cholesterol (non-HDL-C) and systolic BP (SBP). Management algorithms were used for both groups. Carotid ultrasound and echocardiography were performed at baseline and after 36 months.
Results: No differences were observed in baseline hemoglobin A1c between treatment groups nor any significant change in A1c after 36 months in either group. Baseline A1c, however, was significantly and negatively related to achieving LDL-C (P = .007), non-HDL-C (P = .03) and SBP targets (P = .007) and to changes in LDL-C (P = .007), non-HDL-C (P = .03) and SBP (P = .001) in both groups. Baseline A1c failed to predict progression of carotid intima medial thickness (CIMT) (P = .42) or left ventricular mass index (LVMI) (P = .10), nor was it related to the effects of lipid and BP lowering on CIMT and LVMI over 36 months.
Conclusions: In diabetic adults with no cardiovascular disease events, A1c was negatively associated with ability to achieve LDL-C, non-HDL-C and SBP goals but was not independently related to treatment-associated changes in CIMT or LVMI over 36 months.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures



References
-
- Action to Control Cardiovascular Risk in Diabetes Study Group. Gerstein HC, Miller ME, Byington RP, Goff DC, Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, Jr, Probstfield JL, Simons-Morton DG, Friedewald WT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59. - PMC - PubMed
-
- Bjarnegard N, Arnqvist HJ, Lindstrom T, Jonasson L, Jonsson A, Lanne T. Long-term hyperglycaemia impairs vascular smooth muscle function in women with type 1 diabetes mellitus. Diab Vasc Dis Res. 2009;6:25–31. - PubMed
-
- Chen Y, Huang Y, Li M, Bi Y, Zhang Y, Gu W, Ning G. Association of arterial stiffness with HbA1c in 1000 type 2 diabetic patients with or without hypertension. Endocrine. 2009;36:262–7. - PubMed
-
- Davidson MB, Hu T, Hoar B, Stevenson C, Hoogwerf BJ. The relationship of glycemic control and triglycerides in patients with diabetes mellitus: a précis Database Study. Diabetes Obes Metab. 2009;11:118–22. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical